Aerie Pharma's Glaucoma Drug Succeeds in Mid-stage TrialAerie Pharma's Glaucoma Drug Succeeds in Mid-stage Trial

Aerie Pharmaceuticals Inc said its single-drop glaucoma treatment was shown to be superior to each of its two components in a mid-stage trial. Reuters Health Information
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news